“Tanshinone IIA Attenuates Interleukin-17A-Induced Systemic Sclerosis Patient-Derived Dermal Vascular Smooth Muscle Cell Activation via Inhibition of the Extracellular Signal-Regulated Kinase Signaling Pathway”. 2015. Clinics 70 (4): 250-56. https://doi.org/10.6061/clinics/2015(04)06.